Navigation Links
Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle)
Date:9/1/2011

SANTA ROSA, Calif., Sept. 1, 2011 /PRNewswire/ -- Today, Osseon® Therapeutics, Inc. launched the Osseoflex®SN (steerable needle). Osseoflex SN is the newest in Osseon's suite of minimally invasive products for treatment of spinal compression fractures.

(Photo:  http://photos.prnewswire.com/prnh/20110901/SF61461)

The Osseoflex SN allows direct unipedicular access to the entire vertebral body. The Osseoplasty™ procedure offers unparalleled flexibility and control for percutaneous vertebral augmentation, cement delivery, and fracture stabilization, resulting in significant pain relief for most patients within the same day.

"Osseoflex SN is the next generation of steerable, minimally invasive cement delivery devices for the treatment of osteoporosis and related bone diseases and injuries. Our technology for vertebral compression fracture treatment offers increased precision, less operating time for physicians and decreased risk for patients," said John Stalcup, Ph.D., Osseon's CEO and President.

Osseon Therapeutics currently markets Osseoflex®SN (steerable needle), Osseoperm® (bone cement), Osseoflex®DR (steerable bone drill), Osseoflex®BT (steerable bone tamp), and Osseoflex®Access (bone access kit). Together, Osseon's suite of products provides groundbreaking biomedical devices for physicians who treat vertebral compression fractures due to osteoporosis, myeloma, and acute osteo-traumatic injuries.

About Osseon

Osseon Therapeutics, Inc. focuses on bringing to market alternative minimally invasive treatments for degenerative bone and joint disease. Headquartered in Santa Rosa, CA, the company's groundbreaking technology and delivery systems provide efficacy and safety competitive with all other commercial solutions, while delivering superior efficiency and cost. By improving the treatment of compression fractures within the entire thoracic and lumbar spine, Osseon offers alternative solutions to symptomatic patients as well as to the physicians and medical facilities that treat them. Osseon's products have received both FDA clearance and the CE Mark for product distribution in the United States and the European Union.

For more information, visit our website at www.osseon.com.


'/>"/>
SOURCE Osseon Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
2. Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill
3. PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization
4. Hill-Rom Announces Fourth Quarter 2011 Dividend
5. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
6. Sequenom Announces Participation at William Blair and Company 5th Annual Emerging Growth Stock Conference
7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
8. Concord Medical Services Announces the Appointment of Mr. Adam Sun as Acting Chief Financial Officer
9. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
10. ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
11. Caliper Life Sciences Announces IVIS Spectrum CT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ATLANTA , Feb. 10, 2016  LexisNexis® ... and technology, today announced the launch of ... analytics solution that helps improve and optimize the ... evaluation of performance using severity-adjusted scores. By measuring ... a critical solution to deliver better outcomes, improve ...
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... Mast Therapeutics, Inc. (NYSE MKT: ... sickle cell disease and heart failure, today announced the ... at a price to the public of $0.275 per ... Company,s common stock and one warrant to purchase one ... price of $0.42 per share. The warrants are exercisable ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the ... available to physicians. The integration will enable Allscripts users to post open appointments ... free mobile app. , The partnership gives Everseat substantial added power to help ...
(Date:2/10/2016)... Jacksonville, Florida (PRWEB) , ... ... ... of North Florida – 1 UNF Drive, Jacksonville, FL 32224, February 26th: ... $30, February 27th: Elite Division - Time: 7:00pm – 10:00pm | Ticket ...
(Date:2/10/2016)... ... 2016 , ... Workrite Ergonomics, who is celebrating their 25th year of business ... being an internationally recognized leader in their industry. , "We are very proud of ... of Workrite. “Workrite recognized the importance of good ergonomics before most of our ...
(Date:2/10/2016)... ... , ... Anxiety of older Americans over steep cost increases of prescription drugs ... ago, according to The Senior Citizens League (TSCL). Since last fall, ... rapidly rising costs. “The implications are chilling, particularly for people with chronic health ...
(Date:2/10/2016)... Puente, California (PRWEB) , ... February 09, 2016 ... ... Medicine students, faculty and staff helped give free oral screenings to 150 children ... Feb. 5, 2016. , The College of Dental Medicine joined Chinese American Dental ...
Breaking Medicine News(10 mins):